U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Go back to U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business
KKR & CO. L.P. (NYSE: KKR) Delayed: 108.48 +1.46 (1.36%)
Previous Close $107.02    52 Week High $17.84 
Open $110.11    52 Week Low $10.89 
Day High $110.11    P/E 47.17 
Day Low $107.67    EPS $2.30 
Volume 2,680,379